Showing results 1 to 15 of 15
A miR-194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma- Kang, Hoin;
- Heo, Sungeun;
- Shin, Jung Jae;
- Ji, Eunbyul;
- Tak, Hyosun;
- Ahn, Sojin;
- Lee, Kyung Jin;
- Lee, Eun Kyung;
- Kim, Wook
- 2019-11-01
- Journal of Pathology, Vol.249 No.3, pp.395-408
- John Wiley and Sons Ltd
An epidermal growth factor receptor-targeting immunotoxin based on IgG shows potent antitumor activity against head and neck cancer- Huang, Mei;
- Park, Jisoo;
- Seo, Jina;
- Ko, Sanghwan;
- Yang, Yoon Hee;
- Lee, Yeaji;
- Kim, Hyo Jeong;
- Lee, Bok Soon;
- Lee, Yun Sang;
- Ko, Byoung Joon;
et al
- 2024-07-15
- FASEB Journal, Vol.38 No.13
- John Wiley and Sons Inc
Effective deactivation of A549 tumor cells in vitro and in vivo by RGD-decorated chitosan-functionalized single-walled carbon nanotube loading docetaxel- Li, Bin;
- Zhang, Xiao Xue;
- Huang, Hao Yan;
- Chen, Li Qing;
- Cui, Jing Hao;
- Liu, Yanli;
- Jin, Hehua;
- Lee, Beom Jin;
- Cao, Qing Ri
- 2018-05-30
- International Journal of Pharmaceutics, Vol.543 No.1-2, pp.8-20
- Elsevier B.V.
Gambogic acid triggers vacuolization-associated cell death in cancer cells via disruption of thiol proteostasisoa mark- Seo, Min Ji;
- Lee, Dong Min;
- Kim, In Young;
- Lee, Dongjoo;
- Choi, Min Koo;
- Lee, Joo Youn;
- Park, Seok Soon;
- Jeong, Seong Yun;
- Choi, Eun Kyung;
- Choi, Kyeong Sook
- 2019-03-01
- Cell Death and Disease, Vol.10 No.3
- Nature Publishing Group
Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape- Lee, Ji Eun;
- Kang, Yeo Wool;
- Jung, Kyung Hee;
- Son, Mi Kwon;
- Shin, Seung Min;
- Kim, Ji Sun;
- Kim, Soo Jung;
- Fang, Zhenghuan;
- Yan, Hong Hua;
- Park, Jung Hee;
et al
- 2021-06-01
- Cancer Letters, Vol.507, pp.97-111
- Elsevier Ireland Ltd
KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer- Kang, Yeo Wool;
- Lee, Ji Eun;
- Jung, Kyung Hee;
- Son, Mi Kwon;
- Shin, Seung Min;
- Kim, Soo Jung;
- Fang, Zhenghuan;
- Yan, Hong Hua;
- Park, Jung Hee;
- Han, Boreum;
et al
- 2018-12-01
- Cancer Letters, Vol.438, pp.174-186
- Elsevier Ireland Ltd
Preclinical efficacy and safety of an anti-human vegfa and anti-human nrp1 dual-targeting bispecific antibody (Idb0076)oa mark- Ko, Jong Hee;
- Kwon, Hyuk Sang;
- Kim, Bomin;
- Min, Gihong;
- Shin, Chorong;
- Yang, Seok Woo;
- Lee, Seong Wook;
- Lee, Youngmin;
- Hong, Dahae;
- Kim, Yong Sung
- 2020-06-01
- Biomolecules, Vol.10 No.6, pp.1-18
- MDPI AG
Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosisoa mark- Park, Seok Soon;
- Lee, Dong Min;
- Lim, Jun Hee;
- Lee, Dongjoo;
- Park, Sang Jun;
- Kim, Hwan Myung;
- Sohn, Seonghyang;
- Yoon, Gyesoon;
- Eom, Young Woo;
- Jeong, Seong Yun;
et al
- 2018-03-08
- Carcinogenesis, Vol.39 No.3, pp.458-470
- Oxford University Press
Size-Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targetingoa mark- Kang, Homan;
- Rho, Sunghoon;
- Stiles, Wesley R.;
- Hu, Shuang;
- Baek, Yoonji;
- Hwang, Do Won;
- Kashiwagi, Satoshi;
- Kim, Moon Suk;
- Choi, Hak Soo
- 2020-01-01
- Advanced Healthcare Materials, Vol.9 No.1
- Wiley-VCH Verlag
1
